Marqeta reported a solid Q3 2024 with notable growth in processing volume, though profitability challenges remain.
Tesla stock triggered a sell signal from a recent buy point Monday, while Palantir surged more than 13% on earnings.
Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.